Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
設定
言語
日本
通貨
USD
テーマ
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
株式のランク #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
株価
$59.98
最終同期: 2024-12-13
時価総額
$1.22B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Longboard Pharmaceuticals, Inc. (LBPH)

カテゴリー

Healthcare
Longboard Pharmaceuticals, Inc.（LBPH）の発行済株式数
September 2024 時点の発行済株式数 38.96M
Longboard Pharmaceuticals, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 38.96M です。December 2022 の終わりには、同社は 17.15M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Longboard Pharmaceuticals, Inc.（LBPH）の発行済株式数の履歴（2020 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 38.96M 71.42%
2023 22.73M 32.51%
2022 17.15M 0.47%
2021 17.07M -3.38%
2020 17.67M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 551.74%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 59.62%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 1,129.32%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 916.49%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH